
Get clinician-approved Guanfacine for brain fog and cognitive dysfunction.
Only charged if approved
90-day supply + shipping
With RTHM discount
Paid every 90 days
(only charged if approved)
90-day supply + shipping, paid to the pharmacy
With RTHM discount
Guanfacine acts on the prefrontal cortex, improving memory, attention, and executive functioning to help clear brain fog and restore mental clarity.
By strengthening neural connections, guanfacine helps maintain sustained attention and reduces distractibility, making daily tasks more manageable.
Guanfacine helps stabilize blood pressure by reducing sympathetic nervous system activity, beneficial for those with dysautonomia-related hypertension.
Guanfacine is particularly effective for:
Patients with Long COVID, ME/CFS, or dysautonomia experiencing these symptoms may benefit from guanfacine.
Guanfacine is generally safe and well-tolerated, though mild side effects such as drowsiness or dizziness may occur. Patients with certain cardiac, kidney, or liver conditions should consult their healthcare provider before use.
Guanfacine may not be suitable for individuals with:
Guanfacine's action on alpha-2A adrenergic receptors in the prefrontal cortex supports attention, working memory, and impulse control. Its promising off-label use includes conditions such as PTSD, traumatic brain injury, ME/CFS, and Long COVID.
"Guanfacine's mechanism of action in treating prefrontal cortical disorders: Successful translation across species"
Guanfacine has shown potential to alleviate cognitive dysfunction by improving blood flow, modulating brain activity, and addressing the physical and mental fatigue often associated with complex illnesses.
"Guanfacine"
A novel treatment using guanfacine combined with N-acetylcysteine (GXN) was developed for ME/CFS brain fog. The three-patient case report indicated improvement in all participants with good tolerability.
"Guanfacine Plus N-Acetylcysteine for the Treatment of Cognitive Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): An Open-Label, Proof of Concept Trial (GXN in ME/CFS)"
Guanfacine's action on alpha-2A adrenergic receptors in the prefrontal cortex supports attention, working memory, and impulse control. Its promising off-label use includes conditions such as PTSD, traumatic brain injury, ME/CFS, and Long COVID.
"Guanfacine's mechanism of action in treating prefrontal cortical disorders: Successful translation across species"
View StudyGuanfacine has shown potential to alleviate cognitive dysfunction by improving blood flow, modulating brain activity, and addressing the physical and mental fatigue often associated with complex illnesses.
"Guanfacine"
View StudyA novel treatment using guanfacine combined with N-acetylcysteine (GXN) was developed for ME/CFS brain fog. The three-patient case report indicated improvement in all participants with good tolerability.
"Guanfacine Plus N-Acetylcysteine for the Treatment of Cognitive Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): An Open-Label, Proof of Concept Trial (GXN in ME/CFS)"
View Study"I was able to go back to school, work full time. I didn't crash, didn't have PEM. After getting to 1mg I had energy and mental stamina that allowed me to use my brain for more than an hour a day!"
"Brain fog improved from 4 to 7. I never thought my brain fog would improve. All because of guanfacine."
"I had moderate cfs/me with moderate brain fog… once I changed the dose, the brain fog went away completely!"